Schedule 13G ownership disclosure
CAMP4 Therapeutics Corp.
Security class unavailable · CUSIP: 13463J101
Event date: 2024-10-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 471,415
- Percent of class
- 2.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-110632
- Form type
- SC 13G
- Filer
- Camp4 Therapeutics Corp
- CIK
- CIK 1736730
- Filed
- Oct 22, 2024
- Reporting period
- Oct 15, 2024
- Description
- Schedule 13G beneficial ownership